2021
Tofacitinib for the Treatment of Refractory Palmoplantar Psoriasis: A Case Series
Muzumdar S, Leonardi C, Strober B. Tofacitinib for the Treatment of Refractory Palmoplantar Psoriasis: A Case Series. Journal Of Psoriasis And Psoriatic Arthritis 2021, 6: 93-98. DOI: 10.1177/2475530321995516.Peer-Reviewed Original ResearchPalmoplantar psoriasisCase seriesEfficacy of tofacitinibRecalcitrant palmoplantar psoriasisSubtypes of psoriasisPsoriasis refractorySystemic therapyPatients' qualityNew medicationsEffective therapyPsoriasis phenotypesSpecific cytokinesPsoriasisTofacitinibTherapyTreatmentMedicationsPatientsCytokinesSubtypes
2020
The Skin Microbiome of Inverse Psoriasis
Chung J, Strober B, Weinstock G. The Skin Microbiome of Inverse Psoriasis. 2020, 203-215. DOI: 10.1002/9781119593058.ch10.Peer-Reviewed Original ResearchInverse psoriasisNon-lesion sitesSkin microbiomeSkin sitesHealthy skin sitesNon-lesional sitesPlaque psoriasis patientsSubtypes of psoriasisLongitudinal study designPsoriasis patientsIntertriginous sitesUnknown etiologyPsoriasisSkin diseasesStudy designMore subjectsPilot studyFurther studiesPatientsMicrobial differencesLesionsCohortMicrobiomeSubjectsPathogenesis